Funding for this research was provided by:
National Institute of Environmental Health Sciences (R21ES029616, R21ES029493), R21ES029460, P30ES030285)
Received: 19 May 2020
Accepted: 12 January 2021
First Online: 19 January 2021
Ethics approval and consent to participate
: The protocols for this study has been reviewed and approved by the Committee for the Protection of Human Subjects at the Baylor College of Medicine (IRB #: H<sup>− 42111</sup>), Oregon State University (IRB#: 8146) and The University of Texas Health Science Center at Houston (IRB#: HSC-SPH-17-0846).
: This manuscript does not contain any individual person’s data in any form.
: Kimberly Anderson and Diana Rohlman disclose a financial interest in MyExposome, Inc., which is marketing products related to the research being reported. The terms of this arrangement have been reviewed and approved by Oregon State University in accordance with its policy on research conflicts of interest. The authors have no other competing interests to disclose. The other authors declare they have no actual or potential competing financial interests.